Atai Life Sciences Gross Profit 2020-2025 | ATAI

Atai Life Sciences gross profit from 2020 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Atai Life Sciences Annual Gross Profit
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $20
2020 $0
2019 $0
Atai Life Sciences Quarterly Gross Profit
(Millions of US $)
2025-03-31 $2
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31
2021-12-31 $0
2021-09-30 $0
2021-06-30
2021-03-31 $20
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.463B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.351B 19.07
Encompass Health (EHC) United States $12.186B 25.83
DaVita (DVA) United States $10.288B 14.47
Chemed (CHE) United States $8.410B 26.43
Elanco Animal Health (ELAN) United States $6.675B 14.30
Option Care Health (OPCH) United States $5.351B 23.85
RadNet (RDNT) United States $4.313B 273.76
Amedisys (AMED) United States $3.087B 20.77
LifeStance Health (LFST) United States $2.310B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.390B 34.43
U.S Physical Therapy (USPH) United States $1.139B 29.41
Aveanna Healthcare Holdings (AVAH) United States $1.040B 59.22
Pennant (PNTG) United States $0.990B 36.34
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00